Comparing policies that limit pharmacy out-of-pocket expenses in the commercial fully-insured market
In recent years, several states have implemented policies in the commercial fully-insured market that attempt to limit patient out-of-pocket (OOP) expenses for pharmacy benefits. This report examines key considerations for states, payers and patients for a range of policies, including the potential impact on member premiums and OOP costs for patients that rely on specialty drugs.
This article was commissioned by Bristol Myers Squibb.
About the Author(s)
Sally Maraldo
Comparing policies that limit pharmacy out-of-pocket expenses in the commercial fully-insured market
This report examines key considerations for states, payers, and patients for a range of policies, including the potential impact on member premiums and out-of-pocket costs for patients that rely on specialty drugs.